In a bid to challenge the Maharashtra FDA decision to cancel license to manufacture cosmetics from the Mulund facility, Johnson and Johnson has moved the Bombay HC, reports CNBC-TV18's Ashmit Kumar.
first published: Jul 19, 2013 07:21 pm
A collection of the most-viewed Moneycontrol videos.
Can Nifty Stage A Friday Fightback After Hitting 3-Week Low? Pine Labs IPO Opens | Opening Bell Live
Nifty Stays Below 25,600 Amid Expiry-Led Volatility; Grasim, Hindalco In Focus| Closing Bell Live
Pine Labs’ Rs 3,900 Cr IPO| CEO Amrish Rau On Why The Issue Size Was Cut & The Post-IPO Gameplan
Can Nifty Claw Back Above 25,600 Or Will Sensex Expiry Cap The Upside?| Opening Bell Live
